CANDIDATE INFORMATION PACK DIRECTOR OF CANCER IMAGING PETER MACCALLUM CANCER CENTRE “Peter MacCallum Cancer Centre strives to be the best in cancer care, accelerating discovery, translating to cures. How we go about our work is as important as what we achieve. Everything we do is underpinned by our core values, Excellence, Compassion and Innovation.” CANDIDATE INFORMATION PACK Director of Cancer Imaging TABLE OF CONTENTS Executive Summary 3 Peter MacCallum Cancer Centre 4 Director of Cancer Imaging 8 Employment Terms & Conditions 11 How to Apply 12 HardyGroup | IN CONFIDENCE 2 CANDIDATE INFORMATION PACK Director of Cancer Imaging EXECUTIVE SUMMARY The Peter MacCallum Cancer Centre (Peter Mac) is Australia’s only public hospital solely dedicated to cancer treatment, research and education. With a staff of over 2,521FTE highly talented and committed people, a total budget of $726 million (including a research budget of $114.9 million), as well as new facilities and equipment, Peter Mac delivers high quality care and treatment for individual patients, and improves the health and wellbeing for all Victorians affected by cancer. The Cancer Imaging Division of the organisation provides high quality specialised diagnostic imaging and treatment to cancer sufferers, supporting the clinical teams managing their care. Cancer Imaging at Peter Mac includes Radiology and Molecular Imaging, offering a full range of diagnostic, interventional and radionuclide services for clinical and research purposes. As Director, you will provide leadership to around 40 medical and research staff across Radiology and Molecular Imaging and be responsible for driving the development and implementation of innovative strategy that embraces opportunities and delivers clinical excellence and innovative research outcomes. The prestigious Peter Mac seeks to appoint a world class Director, who is at the forefront of cancer care and research. As an experienced Radiologist or Nuclear Medicine Specialist and a leader in the field, you have an impressive academic record, and have a reputation for building effective and collaborative relationships. You possess strategic acumen and the ability to play a leading role in influencing the future of Cancer Imaging. Peter Mac has the facilities, experienced staff and commitment to provide the best care possible that allows for a Director to make a significant contribution. Your impact could be endless. HardyGroup | IN CONFIDENCE 3 CANDIDATE INFORMATION PACK Director of Cancer Imaging PETER MACCALLUM CANCER CENTER Peter MacCallum Cancer Centre (Peter Mac) is a Victorian public health service and a world-leading comprehensive cancer centre seeking to excel across all spheres of clinical care, research and education. Peter Mac has the largest cancer research enterprise in Australia and provide treatment to about 40,000 people with cancer each year. They have a leading role in fundamental, translational and clinical cancer research that drives excellence in cancer care. Established 70 years ago when Sir Peter MacCallum and Dr Rutherford Kaye-Scott convinced the Victorian Government to set up Victoria’s first dedicated cancer centre, it had humble beginnings, starting in just one room of the then Queen Victoria Hospital in Melbourne. By 1986, when its name changed from the ‘Cancer Institute’ to the ‘Peter MacCallum Cancer Institute’, it occupied 11 different sites across Melbourne. These locations were consolidated in 1990 on the site of the former St Andrews Hospital in East Melbourne. In June 2016, Peter Mac moved into its new home within the $1 billion purpose-built Victorian Comprehensive Cancer Centre building, located at the entrance to Melbourne’s Parkville bio-medical precinct. The guiding principles of the organisation are outlined in a quote by Sir Peter MacCallum that he made 70 years ago that are still relevant today: “We are a cancer centre unsurpassed in the world, where humanity, caring service and relentless research share equal value. Nothing but the best is good enough in the treatment of cancer.”– Sir Peter MacCallum This sense of purpose and commitment to making life better for people affected by cancer continues at Peter MacCallum Cancer Centre. Currently the organisation known as Peter Mac has five sites across Victoria in Melbourne, Bendigo, Box Hill, Moorabbin, and Sunshine. The main site is in the Victorian Comprehensive Cancer Centre building in Melbourne delivers cancer care through our public hospital, conducts research and provide cancer education to health professionals and cancer specialists. Peter Mac is one of the world’s leading cancer research, education and treatment centres globally and is Australia’s only public hospital solely dedicated to caring for people affected by cancer. Peter Mac aims to lead the way in a new era of cancer care, research, education and control. Our unique laboratory bench-to- bedside approach; highly talented and committed people; new facilities and local and international partnerships all combine in pursuit of our goal to improve and save lives. HardyGroup | IN CONFIDENCE 4 CANDIDATE INFORMATION PACK Director of Cancer Imaging VALUES Excellence Ensuring clinical practice is evidence-based, patient-centred, and provided by qualified and experienced staff. Innovation Striving to ensure that innovation is fostered by supporting research and a learning culture. Compassion Adhering to the strongest ethical standards to ensure a culture of openness, mutual respect and trust. SERVICES Ground-breaking scientific discoveries and life-changing treatments are creating new hope for people with cancer. Advances in molecular and genomic medicine are transforming the way they think about how cancer develops and how they detect and treat cancer. At Peter Mac, normal days are extraordinary. They relentlessly pursue research discoveries and innovative clinical practices that are game changers in cancer treatment. CANCER IMAGING Cancer Imaging at Peter Mac includes Radiology and Molecular Imaging (PET, Nuclear Medicine and Therapy). We offer a full range of diagnostic, interventional and radionuclide services for clinical and research purposes. We also assist in surgical and radiation therapy planning services for inpatients and outpatients referrals. Peter Mac operates 4 PET/CT scanners, 2 SPECT/CT scanners, 1 diagnostic and 1 dedicated interventional CT scanners, 2 diagnostic and 1 interventional ultrasound rooms, 1 3T MRI scanner, 1 angiography suite, 1 fluoroscopy suite, 2 digital x-ray rooms, 1 mobile digital x-ray machine, 1 mammography unit and 2 bone marrow biopsy rooms. We also perform novel PET imaging including Ga-68, I-124 and Zr-89, and run a high volume radionuclide therapy service with more than 2300 Lu-177 therapies each year. The Prostate Cancer Theranostics and Imaging Centre (ProsTIC) program at Peter Mac is integrated within Cancer Imaging and is a world-leader in Nuclear Medicine theranostics. This treatment for prostate cancer involves targeting prostate specific membrane antigen (PSMA) on prostate cancer cells – first with a radioactive molecule to reveal the cancer’s spread via a PET scan and then a similar radioactive molecule that kills cancer cells. Peter Mac has pioneered research globally, performing our first PSMA PET scan in 2014, and our first PSMA therapy in 2015. The ProsTIC program has three aims: • Accelerate clinical trial research: Expand the portfolio of clinical trials investigating the use of PSMA PET imaging and therapy targeting areas of high-impact need that are not currently being addressed. HardyGroup | IN CONFIDENCE 5 CANDIDATE INFORMATION PACK Director of Cancer Imaging • Education and Leadership: Establish a global hub of excellence to educate doctors, scientists, patients and the community about the application and benefits of this new technology. • Discovery research: Further investigate next generation targets, develop biomarkers to predict and monitor response to PSMA therapy, optimise new combinations with PSMA therapy in pre- clinical models, explore the use of radio-guided surgery and artificial intelligence image interpretation. RADIOLOGY MOLECULAR IMAGING • CT with dual energy capabilities • PET/CT • MRI • SPECT/CT • Mammography • Radionuclide Therapy • General radiography • Peptide receptor radionuclide therapy • Interventional Services (PRRT) for neuroendocrine tumours • Angiography & fluoroscopy services • Prostate-specific membrane antigen • Core biopsies and needle aspirations (PSMA) therapy for prostate Ca under imaging guidance • Iodine-131 thyroid therapy • Microwave or other local ablative tumour • Radioimmunotherapy (RIT) ablation under imaging guidance • Radiation Therapy and Surgical Planning • Hookwire localisations Services • Thoracentesis, paracentesis and PleurX • Radiopharmacy and Radiochemistry procedures Laboratories • Preclinical imaging laboratory HardyGroup | IN CONFIDENCE 6 CANDIDATE INFORMATION PACK Director of Cancer Imaging Five Interrelated Strategic Pillars Strategic Directions 2020 – 2025 Implementing the Strategic Pillars, Peter Mac pursue three ‘Strategic Enablers’: • High-trust, high-performance culture • Sustainability • Digital and connected health HardyGroup | IN CONFIDENCE 7 CANDIDATE INFORMATION PACK Director of Cancer Imaging DIRECTOR OF CANCER IMAGING POSITION PURPOSE The Director of Cancer Imaging (The Director) will lead and manage the Radiology and Molecular Imaging clinical teams within the Department of Cancer Imaging and support the General Manager – Cancer Imaging by contribution